Introduction
New therapies aimed at tissue repair in regions which are hardship to heal, the bones of the skull and the jaw has used cell therapy osteogenic with osteoinductor growth factors's and vehicles biocompatible 1 . At the context the use of a modern therapeutic arsenal, some research associate mesenchymal stem cells (MSC) with different growth factors, among them, the factors coming from the Platelet Rich Plasma (PRP), important in the induction of bone formation 2 .
MSC are somatic stem cells present in specialized niches in the perivascular regions of adult tissues 3, 4 , with the potential to differentiate into multilineage cell, among them, the patients with osteogenic phenotype 5, 6 . This cell type is routinely isolated from different tissues, especially bone marrow (BM), and widely expanded through successive mitoses. On cultures, exhibit inherent properties such as fibroblastoid cell shape, adhesion to plastic substrate, ability to self-renewal and ability to differentiate, under appropriate conditions of cultivation in different cell types 7 .
The plasticity coupled with expansion hability, immunomodulatory effects and the possibility to be vector to the therapeutic genes, make this group cellular target of great interest in regenerative medicine 8, 9 .
Platelet Rich Plasma (PRP) has been described as a biomaterial accelerator of bone formation that contains blood proteins and many platelet-releasing of different types and amounts of growth factors (GF) with osteoinductive characteristics 10, 11 .
The basic mechanisms and interactions of soluble factors released by the plasma with undifferentiated cells from stroma are not well elucidated 2 . In vitro studies have demonstrated that GF released by the plasma are strongly mitogenic for MSC and osteoblast lineage cells A total of 40 male mice of lineage C57BL/6, average body weight of 30.0 grams, six months old. Eight animals were blood donors to obtain platelet rich plasma (PRP), eight animals were bone marrow donors for the accomplishment of cell culture and the remaining 24 were used for experiments in vivo, were divided into two equals experimental groups.
The animals were housed individually in cages of 0.15 m², under a photoperiod of 12 hours, with controlled temperature and humidity, minimal noise, solid and fed chow and water ad libitum.
Obtaining the PRP
Eight animals were anesthetized using isoflurane at a gas chamber, and contained in the supine position. Subsequently, sternal thoracotomy was performed, the left ventricle was punctured with a 25gauge needle, and collected the entire circulating blood volume, approximately 2.0mL per animal. The blood was immediately transported to sterile bottle containing sodium citrate and centrifuged for 5 minutes, the speed of 1500rpm. After centrifugation, the plasma was removed and placed in another jar, and again centrifuged for 5 minutes at 1500rpm. With the aid of an adjustable automatic pipette in 100.0µL, the superficial phase of the plasma was discarded, leaving only a portion rich in platelets. The total volume of plasma was subjected to counting and distributed in twelve centrifuge tubes, each containing 50.0µL of plasma plus 25.0µL of calcium gluconate 10%, which were placed in a water bath at 37°C until freeze protection plasma. After the formation of the PRP gel, the vials were sealed and taken to the operating room. The preparation of plasma happened moments before the application.
Culture of mesenchymal stem cells
Primary culture cells were collected from bone marrow of adult mice transgenic C57BL/6 for the reporter gene gfp (green fluorescens protein) and deposited in the growth plate with cell culture medium and kept in incubator at 37°C in 5% CO 2 and 95% humidity. When cell growth had averaged 80% confluent cells was performed trypsinization, counting and replating of these cells in culture flasks of 25.0 cm 2 .
Expansion of primary culture
The culture medium was completely removed from the bottle and the bottles were washed with 3.0 mL of phosphate saline buffering solution (PBS 1x, pH 7.2). Then, the cells adhered to the bottom of the bottle were trypsinized with 0.25% trypsin solution and incubated at 37ºC in 5% CO 2 and 95% humidity 
FACS analysis
Cells from the fourth passage were harvested with trypsin, The samples were analyzed using a FACScan cytometer and data were analyzed using CELLQUEST softaware (Becton Dickinson).
Experiments in vivo
The 24 animals were divided into two equal experimental groups, control group (CG) and group of association MSC/PRP (MPG). All underwent the same stress level as the manipulation and the experimental groups were conducted simultaneously.
Preceding to surgery, mice were given prophylactic antibiotic therapy with enrofloxacin (10.0mg/kg, IM) and analgesics based on morphine (5.0mg/kg, SC), which lasted for three days and every 8 hours, targeting the pain control.
The mice were subjected to premedication with xylazine 
Statistical analysis
Statistical analysis was performed using specific software was performed independent analysis of samples by applying the Student t test. To that end, we adopted a level of rejection of the null hypothesis of 5% (p≤0.05).
Microscopic evaluation
The material was submitted to routine histologic processing, embedded in paraffin and sliced (5.0 mm thick) with a impact microtome with razor tungsten, involving the entire area of the defect and the edges of the receptor bone (cut lengthwise) and subsequently was stained by hematoxylin and eosin (H&E). The samples were evaluated for the presence and characteristics of the tissue filler, using descriptive histological analysis.
DNA extraction
Genomic DNA was extracted of a culture of MSC gfp + bone fresh animal gfp -(negative control) and a paraffin embedded samples containing the bone tissue in the defect region and cell transplantation, according to the protocol of the kit. The samples that were embedded in paraffin were deparaffinized and rehydrated prior to the steps of DNA extraction protocol, described by Nascimento et al. 13 .
Polymerase Chain Reaction (PCR)
PCR was carried out to the amplification of a fragment A final extension step was performed at 72°C for 7 minutes. In MPG, angiogenesis was higher with larger vessels than displayed on the GC. These blood vessels were concentrated mainly on the banks that receives region of formation of new bone and the amount of new vessels was greater than 10 days when compared to other periods in the same group.
At MPG was also seen in granulation tissue and an inflammatory infiltrate consisting of basophilic cells, replacing the region occupied by blood clot, similar to that observed in the CG.
At 10 days, the area of new bone formation, as observed macroscopically, was higher than found in the CG, and widened to the extent that the evaluation period progressed. Also, there was evidence of intense movement originated mobile soft tissues adjacent to the defect toward the center, and the presence of At day 60, identified himself to the larger amount of bone tissue and more organized than had hitherto been observed.
In an analogous manner to that described in previous periods, The sequencing of the PCR products is still being awaited. Beyond all the assistance provided by the MSC, PRP is also considered a rich source of growth factors 15 and stimulating agent formation of new bone. According to data presented by Ball et al. 16 MSC express high levels of VEGF and PDGF receptors, which may explain, among other factors, the exuberant angiogenesis found in GMP.
The presence of PDGF (platelet derived growth factor platelet) has many positive effects on tissue repair including angiogenesis, mitogenesis of bone marrow cells and pre-osteoblasts and activation of the differentiation of mature osteoblasts that stimulate the deposition of bone matrix proteins 15, 17 .
It was found that the MSC/PRP used as treatment of defects in the parietal portion of the skull of the mice led to increased bone formation in the control group, with trend total compensation, however, the end of the evaluation period to 90 days, the defects were not fully met. This feature shows the creation of a critical defect in the calvaria of mice (6.0 mm), in agreement with data available in the literature that consider critical defects with a diameter greater than 2.7 mm 18 . Consequently, as much as treatment with undifferentiated cells and plasma gel has increased the repair process, it was not enough to provide a complete cure.
Statistical analysis confirmed that treatment with the combination MSC / PRP increased bone repair that cause a higher amount of new bone, especially in the first 10 days after treatment, the earliest stage. Moreover, it was concluded that the highest rate of bone healing appears in the control group at 90 days was similar to the rate in the treated group at 30 days. For these data, we can infer that the release of growth factors provided by the MSC and the PRP, caused greater activation of osteoprogenitor cells, increased cell recruitment and activation of cells osteocomprometidas, with consequent increased formation of bone tissue.
The resorbable demineralized cortical membrane, used up the defects in both groups, aimed to prevent the spread of material deposited within the lesion once the mouse has no muscle and subcutaneous tissue in this region of the skull, in sufficient quantity to and sutured to prevent leakage of cells that were used in treatment. In the evaluation performed 30 days in both groups, it was no longer present according to data from the preliminary pilot study, conducted by the authors, who found that it does not influence the bone healing process, being completely absorbed over a period of 15 days.
In the MPG was visualized in the initial evaluation, a marked presence of inflammatory infiltrate of basophilic cells and based on previous statements 8, 14 we can infer that these cells 
Conclusion
The association of mesenchymal stem cells (MSC)
derived from bone marrow of C57BL/6 gfp + with gel autologous PRP applied in critical bone defects produced in the calvaria of C57BL/6 adult mice contributes positively to the process of bone repair.
